4.5 Article

Optimization of enzyme-substrate pairing for bioluminescence imaging of gene transfer using Renilla and Gaussia luciferases

期刊

JOURNAL OF GENE MEDICINE
卷 12, 期 6, 页码 528-537

出版社

WILEY
DOI: 10.1002/jgm.1463

关键词

bioluminescence; coelenterazine; imaging; luciferase; reporter gene; retrovirus

资金

  1. NCI [R01 CA105171, R01 CA121258, R25 CA098010, P50 CA086306, 2U24 CA092865, P30 CA016042]

向作者/读者索取更多资源

Background Bioluminescence imaging (BLI) permits the non-invasive quantification and localization of transduction and expression by gene transfer vectors. The tendency of tissue to attenuate light in the optical region, however, limits the sensitivity of BLI. Improvements in light output from bioluminescent reporter systems would allow the detection of lower levels of expression, smaller numbers of cells and expression from deeper and more attenuating tissues within an animal. Methods With the goal of identifying substrates that allow improved sensitivity with Renilla luciferase (RLuc) and Gaussia luciferase (GLuc) reporter genes, we evaluated native coelenterazine and three of its most promising derivatives in BLI of cultured cells transduced with retroviral vectors encoding these reporters. Of the eight enzyme substrate pairs tested, the two that performed best were further evaluated in mice to compare their effectiveness for imaging vector-modified cells in live animals. Results In cell culture, we observed striking differences in luminescence levels from the various enzyme substrate combinations and found that the two luciferases exhibited markedly distinct abilities to generate light with the substrates. The most effective pairs were RLuc with the synthetic coelenterazine derivative ViviRen, and GLuc with native coelenterazine. In animals, these two pairs allowed similar detection sensitivities, which were eight- to 15-fold higher than that of the prototypical RLuc-native coelenterazine combination. Conclusions Substrate selection can dramatically influence the detection sensitivity of RLuc and GLuc and appropriate choice of substrate can greatly improve the performance of reporter genes encoding these enzymes for monitoring gene transfer by BLI. Copyright (C) 2010 John Wiley & Sons, Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Urology & Nephrology

Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer?

Takafumi Yanagisawa, Shun Sato, Yasushi Hayashida, Yohei Okada, Kosuke Iwatani, Akihiro Matsukawa, Takahiro Kimura, Hiroyuki Takahashi, Shin Egawa, Shahrokh F. Shariat, Jun Miki

Summary: The clinical significance of repeat transurethral resection (reTUR) and surgical margin status after en bloc resection of bladder tumor (ERBT) for pathological T1 (pT1) bladder cancer was assessed. It was found that reTUR did not improve recurrence or progression after ERBT for pT1 bladder cancer. Surgical margin status affected prognosis and reTUR outcomes.

BJU INTERNATIONAL (2023)

Editorial Material Oncology

ASO Visual Abstract: En Bloc Resection Versus Conventional TURBT for T1HG Bladder Cancer: A Propensity Score-Matched Analysis

Takafumi Yanagisawa, Akihiro Matsukawa, Kosuke Iwatani, Shun Sato, Yasushi Hayashida, Yohei Okada, Takashi Yorozu, Wataru Fukuokaya, Keigo Sakanaka, Fumihiko Urabe, Shoji Kimura, Shunsuke Tsuzuki, Masayuki Shimoda, Hiroyuki Takahashi, Jun Miki, Shahrokh F. Shariat, Takahiro Kimura

ANNALS OF SURGICAL ONCOLOGY (2023)

Letter Urology & Nephrology

Reply to Huseyin Besiroglu's Letter to the Editor regarding the article 'Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer?'

Takafumi Yanagisawa, Jun Miki, Shun Sato, Hiroyuki Takahashi, Shahrokh F. Shariat, Takahiro Kimura

BJU INTERNATIONAL (2023)

Review Urology & Nephrology

Role of pelvic drain and timing of urethral catheter removal following RARP: a systematic review and meta-analysis

Takafumi Yanagisawa, Tatsushi Kawada, Hadi Mostafaei, Reza Sari Motlagh, Fahad Quhal, Ekaterina Laukhtina, Pawel Rajwa, Markus von Deimling, Alberto Bianchi, Maximilian Pallauf, Benjamin Pradere, Pierre I. Karakiewicz, Jun Miki, Takahiro Kimura, Shahrokh F. Shariat

Summary: This study aimed to assess the clinical value of routine pelvic drain (PD) placement and early removal of urethral catheter (UC) in patients undergoing robot-assisted radical prostatectomy (RARP). The results showed that routine PD placement has no benefit and early removal of UC may increase the risk of urinary retention.

BJU INTERNATIONAL (2023)

Review Urology & Nephrology

Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023

Takafumi Yanagisawa, Tatsushi Kawada, Markus von Deimling, Ekaterina Laukhtina, Takahiro Kimura, Shahrokh F. Shariat

Summary: This review comprehensively summarizes the evidence on the diagnostic, prognostic, and therapeutic impact of lymph node dissection (LND) during radical nephroureterectomy (RNU) in upper tract urothelial carcinoma (UTUC) patients. The studies show that LND is important for accurate N-staging and has positive effects on prognosis and treatment. Overall, LND during RNU is a standard procedure for high-risk nonmetastatic UTUC, and template-based LND should be recommended.

CURRENT OPINION IN UROLOGY (2023)

Editorial Material Oncology

What is the role of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma?

Takafumi Yanagisawa, Manuela Schmidinger, Harun Fajkovic, Pierre I. Karakiewicz, Takahiro Kimura, Shahrokh F. Shariat

EXPERT REVIEW OF ANTICANCER THERAPY (2023)

Article Oncology

The prognostic significance of the clinical T stage and Grade Group in patients with locally advanced prostate cancer treated via high-dose-rate brachytherapy and external beam radiation

Soshi Kadena, Fumihiko Urabe, Kosuke Iwatani, Hirotaka Suzuki, Yu Imai, Kojiro Tashiro, Shunsuke Tsuzuki, Mariko Honda, Yusuke Koike, Tatsuya Shimomura, Manabu Aoki, Shun Sato, Hiroyuki Takahashi, Kenta Miki, Takahiro Kimura

Summary: This study evaluated the long-term outcomes of patients with locally advanced prostate cancer (PCa) who underwent high-dose-rate brachytherapy (HDR-BT) and external beam radiation therapy (EBRT). The clinical T stage and Grade Group status were identified as significant prognostic factors for patients with locally advanced PCa. HDR-BT was effective in patients with Grade Group <= 4 PCa, even in those with cT3b or cT4 PCa. However, careful monitoring is essential for patients with Grade Group5 PCa, particularly those with cT3b or cT4 PCa.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2023)

Review Health Care Sciences & Services

Neoadjuvant Androgen Receptor Signaling Inhibitors before Radical Prostatectomy for Non-Metastatic Advanced Prostate Cancer: A Systematic Review

Takafumi Yanagisawa, Pawel Rajwa, Fahad Quhal, Tatsushi Kawada, Kensuke Bekku, Ekaterina Laukhtina, Markus von Deimling, Marcin Chlosta, Pierre I. Karakiewicz, Takahiro Kimura, Shahrokh F. Shariat

Summary: This study reviewed several studies on the efficacy of adding androgen receptor signaling inhibitors (ARSIs) as a neoadjuvant treatment for patients with prostate cancer (PCa) undergoing radical prostatectomy (RP). The results suggest that neoadjuvant ARSI + ADT combination therapy improves pathologic response compared to ADT or ARSI alone.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Article Oncology

Clinical characteristics of secondary bladder cancer developing after low-/high-dose-rate brachytherapy to treat localized prostate cancer

Keiichiro Miyajima, Hirotaka Suzuki, Fumihiko Urabe, Kosuke Iwatani, Yu Imai, Keiji Yasue, Takafumi Yanagisawa, Shoji Kimura, Kojiro Tashiro, Shunsuke Tsuzuki, Yusuke Koike, Jun Miki, Steffi Yuen, Takaya Sasaki, Manabu Aoki, Shun Sato, Hiroyuki Takahashi, Kenta Miki, Takahiro Kimura

Summary: A retrospective study was conducted to explore the correlations between clinical attributes and secondary bladder cancer in patients with localized prostate cancer who underwent different types of brachytherapy. The study found that there was no significant increase in the risk of secondary bladder cancer after brachytherapy compared to non-irradiation therapy, but brachytherapy patients had a higher incidence of invasive bladder cancer.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2023)

Review Oncology

An Updated Systematic and Comprehensive Review of Cytoreductive Prostatectomy for Metastatic Prostate Cancer

Takafumi Yanagisawa, Pawel Rajwa, Tatsushi Kawada, Kensuke Bekku, Ekaterina Laukhtina, Markus von Deimling, Muhammad Majdoub, Marcin Chlosta, Pierre I. Karakiewicz, Axel Heidenreich, Takahiro Kimura, Shahrokh F. Shariat

Summary: This study systematically assessed and summarized the safety, oncologic, and functional outcomes of cytoreductive prostatectomy (cRP) in patients with low-volume metastatic prostate cancer (mPCa). The results showed that cRP reduced the risk of cancer-specific survival (CSS) and overall survival (OS) in mPCa patients and had acceptable perioperative complication rates and functional outcomes.

CURRENT ONCOLOGY (2023)

Article Urology & Nephrology

Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective study

Kai Ozaki, Shingo Hatakeyama, Shintaro Narita, Kenichi Hata, Takafumi Yanagisawa, Toshikazu Tanaka, Kyo Togashi, Tomoko Hamaya, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Takahiro Kimura, Tomonori Habuchi, Chikara Ohyama

Summary: This study compared the real-world efficacy and medical costs of upfront treatment with docetaxel (DOC) and abiraterone acetate (ABI) in patients with metastatic hormone-sensitive prostate cancer (mHSPC). The results showed that the upfront DOC group had similar PFS2 rates but lower medical costs compared to the upfront ABI group.

WORLD JOURNAL OF UROLOGY (2023)

Letter Urology & Nephrology

Letter to the Editor Re: Balancing diagnostic advancements with cardiovascular considerations in 5-aminolevulinic acid use for bladder tumors

Fumihiko Urabe, Kagenori Ito, Takahiro Kimura

INTERNATIONAL JOURNAL OF UROLOGY (2023)

Article Cell & Tissue Engineering

Successful reconstruction of the rat ureter by a syngeneic collagen tube with a cardiomyocyte sheet

Shutaro Yamamoto, Kenji Matsui, Yoshitaka Kinoshita, Hiroshi Sasaki, Hidekazu Sekine, Yatsumu Saito, Yasuhide Nakayama, Haruki Kume, Takahiro Kimura, Takashi Yokoo, Eiji Kobayashi

Summary: This study aimed to reconstruct the ureter using subcutaneously prepared autologous collagen tubes in a rat model. It was found that urinary flow supported the epithelial spread of the urothelium into the reconstructed ureter, and neonatal rat cardiomyocyte sheets supported the patency of the regenerated ureter with a layered urothelium.

REGENERATIVE THERAPY (2023)

Review Urology & Nephrology

Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis

Keiichiro Mori, Takafumi Yanagisawa, Satoshi Katayama, Ekaterina Laukhtina, Benjamin Pradere, Hadi Mostafaei, Fahad Quhal, Pawel Rajwa, Marco Moschini, Francesco Soria, David D'andrea, Mohammad Abufaraj, Simone Albisinni, Wojciech Krajewski, Wataru Fukuokaya, Jun Miki, Takahiro Kimura, Shin Egawa, Jeremy Y. C. Teoh, Shahrokh F. Shariat

Summary: Sex is associated with worse survival outcomes in patients with muscle-invasive bladder urothelial carcinoma (MIBC) but not in those with non-muscle-invasive bladder urothelial carcinoma (NMIBC).

WORLD JOURNAL OF UROLOGY (2023)

Article Urology & Nephrology

Combination of docetaxel versus nonsteroidal antiandrogen with androgen deprivation therapy for high-volume metastatic hormone-sensitive prostate cancer: a propensity score-matched analysis

Takafumi Yanagisawa, Takahiro Kimura, Kenichi Hata, Shintaro Narita, Shingo Hatakeyama, Keiichiro Mori, Takayuki Sano, Takashi Otsuka, Yuya Iwamoto, Yuki Enei, Minoru Nakazono, Keigo Sakanaka, Kosuke Iwatani, Akihiro Matsukawa, Mahito Atsuta, Hideomi Nishikawa, Shunsuke Tsuzuki, Jun Miki, Tomonori Habuchi, Chikara Ohyama, Shahrokh F. Shariat, Shin Egawa

Summary: This study found that combining docetaxel with androgen deprivation therapy significantly prolonged overall survival and cancer-specific survival in patients with high-volume metastatic hormone-sensitive prostate cancer compared to nonsteroidal antiandrogen therapy.

WORLD JOURNAL OF UROLOGY (2023)

暂无数据